Alnylam Pharmace. buy Chardan Capital
Start price
16.02.24
/
50%
€139.00
Target price
16.02.25
€209.30
Performance (%)
77.27%
End price
17.02.25
€246.40
Summary
This prediction ended on 17.02.25 with a price of €246.40. The BUY prediction by Chardan_Capital for Alnylam Pharmace. saw massive gains of 77.27%. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -2.939% | -2.939% | 13.932% |
| iShares Core DAX® | -1,50 % | 7,70 % | 5,24 % |
| iShares Nasdaq 100 | 1,38 % | 16,28 % | 36,09 % |
| iShares Nikkei 225® | -1,99 % | 13,11 % | 40,18 % |
| iShares S&P 500 | 0,35 % | 10,82 % | 26,47 % |
Comments by Chardan_Capital for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target lowered by analysts at Chardan Capital from $250.00 to $225.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€229.30
02.05.25
02.05.25
€287.76
02.05.26
02.05.26
12.34%
29.04.26
29.04.26
Stopped prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€281.10
25.03.26
25.03.26
€366.18
25.03.27
25.03.27
-8.36%
29.04.26
29.04.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€236.90
26.02.25
26.02.25
€286.08
26.02.26
26.02.26
18.66%
27.02.26
27.02.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€260.20
11.10.24
11.10.24
€274.17
11.10.25
11.10.25
52.23%
12.10.25
12.10.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€168.60
08.08.23
08.08.23
€228.30
08.08.24
08.08.24
46.56%
09.08.24
09.08.24